Report overview
Commercial Aquaculture Vaccines Are Approved Vaccines That Can Induce Protective Immune Responses In Aquatic Animals. The Mass Production Of Aquatic Species Leads To Changes In Optimal Breeding Conditions, Which Indicates Increased Sensitivity To Infectious/Viral Diseases, Thereby Increasing Increased Demand For Commercial Aquaculture Vaccines, Bacterial Diseases And Zoonotic Infections, Are Major Obstacles To Successful Aquaculture. Facts Have Proved That Commercial Aquaculture Vaccines Are A Better Alternative To Antibiotics Used In Fish Aquaculture, Because Antibiotic Treatment Has Attracted A Lot Of Attention Due To Adverse Effects Such As Bacterial Resistance, Toxicity, And Residual Antibiotics In Aquaculture Food. In Addition, The Increase In Global Fish Consumption And The Prevalence Of Bacterial Infections Between Aquatic Species Are Also Increasing The Use Of Commercial Fish Aquaculture Vaccines.
This report aims to provide a comprehensive presentation of the global market for Commercial Aquaculture Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Aquaculture Vaccines. This report contains market size and forecasts of Commercial Aquaculture Vaccines in global, including the following market information:
Global Commercial Aquaculture Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Commercial Aquaculture Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Commercial Aquaculture Vaccines companies in 2022 (%)
The global Commercial Aquaculture Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Nucleic Acid Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Commercial Aquaculture Vaccines include Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra S. A., Elanco Animal Health Inc, Veterquimica S. A., Ictyogroup, Tecnovax and Nisseiken Co Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Commercial Aquaculture Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Commercial Aquaculture Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Commercial Aquaculture Vaccines Market Segment Percentages, by Type, 2022 (%)
Nucleic Acid Vaccine
Subunit Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Global Commercial Aquaculture Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Commercial Aquaculture Vaccines Market Segment Percentages, by Application, 2022 (%)
Fisheries
Breeding Clinic
Fisheries Research Institute
Global Commercial Aquaculture Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Commercial Aquaculture Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Commercial Aquaculture Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Commercial Aquaculture Vaccines revenues share in global market, 2022 (%)
Key companies Commercial Aquaculture Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Commercial Aquaculture Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Ictyogroup
Tecnovax
Nisseiken Co Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Commercial Aquaculture Vaccines, market overview.
Chapter 2: Global Commercial Aquaculture Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Commercial Aquaculture Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Commercial Aquaculture Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Commercial Aquaculture Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
